A Systematic Review of Treatments for Relapsed/Refractory Mantle Cell Lymphoma

A systematic literature review was conducted to evaluate the clinical effectiveness and safety of treatments for patients with relapsed/refractory mantle cell lymphoma (MCL) unsuitable for intensive treatment. Criteria for inclusion of trials were established prior to the literature review. A search of Medline, Embase and the Cochrane library databases was conducted to identify phase II or III randomised controlled trials (RCTs), published from January 1st 1994 to 29th May 2016. Relevant conference abstracts, citation lists from included articles, published guidelines and on-going clinical trial databases were also searched.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research